UKDigital Finance & Tokenization▲
Zephyr Energy secures up to $15 million non-dilutive financing for Paradox Basin project
Zephyr Energy has lined up non-dilutive financing of up to $15 million for its Paradox Basin project in Utah, with Atlas Oil Company set to be repaid purely from future production, and no shares will be issued or working interest sold. Quantum Blockchain Technologies received US approval for a patent application covering technology to cut redundant calculations in Bitcoin mining hardware and will explore licensing deals with established ASIC manufacturers. Pathos Communications expects first-half revenue to jump 14% to $7.3 million and adjusted EBITDA to rise 31%, as its AI platform and new sales structure drive a roughly 30% increase in monthly client sign-ups and more than double repeat customers. AOTI reported underlying first-half revenue growth of 18%, ahead of full-year guidance, with Veterans Administration demand bouncing back strongly, and said proposed nationwide Medicare coverage for its wound-care technology could be transformative once finalized. Scancell Holdings confirmed its UK fundraise raised £15.7 million, with the retail offer upsized after strong demand, and the money will help fund a global phase III trial of its melanoma treatment alongside its merger with US biotech Neuphoria.
About megatrends
Digital Finance & Tokenization › Miner-Treasury Hybrids Technology
AOTI.LSE · Demand · Positive VA demand bouncing back strongly and proposed nationwide Medicare coverage for wound-care technology.
NEWS.LSE · Demand · Positive First-half revenue jump 14%, adjusted EBITDA up 31%, driven by AI platform and new sales structure increasing client sign-ups 30% and more than doubling repeat customers.
QBT.LSE · Technology · Positive US patent approval for technology to cut redundant calculations in Bitcoin mining hardware, with plans to license to ASIC manufacturers.
SCLP.LSE · Capital · Positive UK fundraise raised £15.7 million with strong retail demand, funding global phase III trial of melanoma treatment and merger with Neuphoria.
ZPHR.LSE · Capital · Positive Secured up to $15 million non-dilutive financing for Paradox Basin project, with no shares issued or working interest sold.